Andrew J Aguirre

53PUBLICATIONS
588CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 30, 2026
FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non-small cell lung cancer.

|Sep 29, 2026
Spatially confined IL-12 programs CAR-NK through mTORC1 to coordinate antitumor immune networks.

|Aug 11, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

|Aug 05, 2026
A dependency map enhanced with next-generation 3D cancer models.

|Jul 17, 2026
Iron overload suppresses LKB1 and induces IL36G anti-tumor immunity in PDAC metastasis.

|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

Pageof 9

Frequent Collaborators

24 joint publications

Brian M Wolpin

14 joint publications

Harshabad Singh

13 joint publications

Kimberly Perez

12 joint publications

Julien Dilly